LIMERICK, Ireland, Dec. 22, 2021 /CNW/ – kneat.com, inc.
(TSX: KSI) ("Kneat" or "the Company"), a leader in
digitizing and automating validation and quality processes, is
pleased to announce that another industry-leading corporation has
selected Kneat as its enterprise validation platform.
The European-headquartered global biopharmaceutical company
employs over 80,000 people, operates in more than 70 countries, and
is currently using Kneat at 11 of its more than 50 manufacturing
sites. Within these 11 sites, this customer has scaled the use of
Kneat's software to multiple validation processes across core
business units, including Specialty Care, Vaccines,
and General Medicines.
With the signing of this three-year Master Services Agreement,
Kneat has been formally appointed as the customer's corporate
enterprise validation solution, allowing it to expand its use of
Kneat efficiently and at speed across the organization.
"We are very pleased that this global leader, one of the world's
most respected healthcare brands, has further put its trust in
Kneat," said Eddie Ryan, Chief
Executive Officer of Kneat. "Their expansion provides additional
evidence of Kneat's product leadership in the category."
Kneat continues to grow its diverse customer base, ranging from
small biotechnology companies to top tier pharmaceutical companies.
Among its customers, Kneat now has Master Services Agreements with
7 of the world's top 10 life sciences companies. The trend of
large, global leaders utilizing Kneat across their organization
continues.
About Kneat
Kneat, a Canadian company with operational headquarters in
Limerick, Ireland, develops and
markets the next generation Kneat Gx software platform. Multiple
business work processes can be configured on the platform from
equipment to computer system validation, through to quality
document management. Kneat's software allows users to author,
review, approve, execute testing online, manage any exceptions and
post approve final deliverables in a controlled FDA 21 CFR Part 11/
Eudralex Annex 11 compliant platform. Macro and micro report
dashboards enable powerful oversight into all systems, projects and
processes globally. Customer case studies are reporting
productivity improvements in excess of 100% and a higher data
integrity and compliance standard. For more information visit
www.kneat.com.
Cautionary and Forward-Looking Statements
Except for the statements of historical fact contained herein,
certain information presented constitutes "forward-looking
information" within the meaning of applicable Canadian securities
laws. Such forward-looking information includes, but is not limited
to, the relationship between Kneat and the customer, Kneat's
business development activities, the use and implementation
timelines of Kneat's software within the customer's validation
processes, the ability and intent of the customer to scale the use
of Kneat's software within the customer's organization and the
compliance of Kneat's platform under regulatory audit and
inspection. While such forward-looking statements are expressed by
Kneat, as stated in this release, in good faith and believed by
Kneat to have a reasonable basis, they are subject to important
risks and uncertainties. As a result of these risks and
uncertainties, the events predicted in these forward-looking
statements may differ materially from actual results or events.
These forward-looking statements are not guarantees of future
performance, given that they involve risks and uncertainties. The
forward-looking information in this press release does not include
a full assessment or reflection of the unprecedented impacts of the
COVID-19 pandemic occurring since the first quarter of 2020 and the
ongoing and developing resulting indirect global and regional
economic impacts. This has resulted in significant economic
uncertainty and even though the company has to date experienced no
significant impact to its operations, any potential impact on our
future is difficult to understand or measure at this time. Kneat
does not undertake any obligation to release publicly revisions to
any forward-looking statement, except as may be required under
applicable securities laws. Investors should not assume that any
lack of update to a previously issued forward-looking statement
constitutes a reaffirmation of that statement. Continued reliance
on forward-looking statements is at an investors' own risk.
SOURCE kneat.com, inc.